References
- Royds JA, Parsons MA, Taylor CB, Timperley WR. Enolase isoenzyme distribution in the human brain and its tumours. J Pathol 1982;137:37–49
- Rider CC, TaylorCB. Evidence for a new formof enolase in rat brain. Biochem Biophys Res Commun 1975;66:814–20
- Fletcher L, Rider CC, Taylor CB. Enolase isoenzymes III. Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys Acta 1976;452:245–52
- Schmechel D, Marangos PJ, Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature (London) 1978;276:834–6
- Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK. Brain enolases as specific markers of neuronal and glial cells. Science 1978;199:313–15
- Esscher T, Steinholtz L, Bergh J,Nou E, Nilsson K, Pahlman S. Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. Thorax 1985;40:85–90
- Odelstad L, Pahlman S, Lackgren G, Larsson E, Grotte G, Nilsson K. Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms’ tumor. J Pediatr Surg1982;17:381–5
- Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurologicaloutcome after out-of-hospitalcardiac arrest: prediction by cerebrospinal fluid enzyme analysis. Arch Neurol1989;46:753–6
- Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovasculardiseases. Stroke 1994;25:558–65
- Mabe H, Suzuki S, Mase M, Umemura A, Nagai H. Serum neuron-specificenolase levels after subarachnoidhemorrhage. Surg Neurol 1991;36:170–4
- Li Y, Wang X, Yang Z. Neuron-specific enolase in patients with acute ischemic stroke and related dementia. Chin Med J 1995;108:221–3
- Garcia-Alix A, Cabanas F, PellicerA, Hernanz A, Stiris TA, Quero J. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants. Pediatrics 1994;93:234–40
- Anneren G, Esscher T, Larsson L, Olsen L, Pahlman S. S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus. Prenat Diagn 1988;8:323–8
- Sorensen K, Brodbeck U, Norgaard-Pedersen B. Determination of neuron specific enolase in amniotic fluid and maternal serum for the prenatal diagnosis of fetal neural tube defects. Clin Chim Acta 1987;162:101–4
- Elimian A, Figueroa R, Verma U, Visintainer P, Sehgal PB, Tejani N. Amniotic fluid neuron-specific enolase: a role in predicting neonatal neurologic injury? Obstet Gynecol 1998; 92:546–50
- Pahlman S, Esscher T, Bergvall P, Odestad L. Purificationand characterization of human neuron-specific enolase: radioimmunoassay development. Tumor Biol 1984;5:127–39
- American College of Obstetricians and Gynecologists. Fetal and Neonatal Neurologic Injury. ACOG Technical Bulletin no. 163. Washington, DC:AmericanCollege ofObstetriciansand Gynecologists, 1992
- Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. N Engl J Med 1986;315:81–6
- Kato K, Ishiguro Y, Ariyoshi Y. Enolase isoenzymes as disease markers: distributionof three enolase subunits (a,b, and g) in various human tissues. Dis Markers 1983;1:213–20
- Anastasiades KD, Mullins RE, Conn RB. Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lungs. Am J Clin Pathol 1987;87:245–9